EV Biologics, Inc. (YECO)
OTCMKTS: YECO · Delayed Price · USD
0.704
0.00 (0.00%)
Mar 19, 2024, 10:48 AM EDT - Market closed

EV Biologics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20172016201520142013
Revenue
9.4742.6446.2344.4642.48
Revenue Growth (YoY)
-77.78%-7.76%3.99%4.65%-
Cost of Revenue
7.9426.1729.3627.526.78
Gross Profit
1.5416.4816.8716.9515.7
Selling, General & Admin
1.3813.294.011.741.58
Other Operating Expenses
-0.10000
Operating Expenses
1.3813.294.011.741.58
Operating Income
0.053.2912.8615.2214.12
Interest Income
00.110.070.020
Interest Expense
0.581.041.31.181.15
Other Expense / Income
-52.190.050.10.01
Pretax Income
-0.52-49.8311.5813.9512.96
Income Tax
0.033.362.93.262.91
Net Income
-0.55-53.198.6810.6910.05
Net Income Growth
---18.82%6.40%-
Shares Outstanding (Basic)
22222
Shares Outstanding (Diluted)
22222
Shares Change
1.08%49.09%4.24%-20.00%-
EPS (Basic)
--22.305.406.945.24
EPS (Diluted)
--22.305.406.945.24
EPS Growth
---22.19%32.44%-
Free Cash Flow
-0.38-23.354.1811.16-2.76
Free Cash Flow Per Share
-0.16-9.792.617.27-1.44
Gross Margin
16.24%38.64%36.49%38.13%36.95%
Operating Margin
0.55%7.71%27.81%34.23%33.23%
Profit Margin
-5.82%-124.73%18.77%24.05%23.66%
Free Cash Flow Margin
-4.00%-54.74%9.03%25.11%-6.49%
Effective Tax Rate
--25.03%23.36%22.44%
EBITDA
0.745.5114.6316.6115.17
EBITDA Margin
7.80%12.91%31.64%37.35%35.70%
Depreciation & Amortization
0.692.221.751.391.06
EBIT
0.053.2912.8715.2214.11
EBIT Margin
0.55%7.71%27.85%34.23%33.22%
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.